🔗 Permalink

Inventor profile of:

JOERG THOMAS REGULA

City:

MUNICH

Country:

Germany

Published Applications:

Last publication date:

2026-02-19

Top Assignees for applications by JOERG THOMAS REGULA

The entities that hold a legal rights for patent applications filed by inventor REGULA JOERG THOMAS:

HOFFMANN-LA ROCHE INC. 30 Little Falls, NJ United States
Hoffmann-La Roche Inc. 13 Nutley, NJ United States
ROCHE GLYCART AG 2 Schlieren, Switzerland
Roche GlycArt AG 2 , Switzerland
Hoffman-La Roche. Inc. 2 Nutley, NJ United States
Hoffman-La Roche Inc. 2 Little Falls, NJ United States
Hofmann-La Roche Inc. 1 Little Falls, NJ United States
Roche Palo Alto LLC 1 Palo Alto, CA United States
F. Hoffmann-La Roche AG 1 Basel, Switzerland

Recent patent applications by REGULA JOERG THOMAS

JOERG THOMAS REGULA from MUNICH, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-19

US20260049160A1

Chemistry; metallurgy

TETRAVALENT MULTISPECIFIC ANTIBODIES

#2 | 2025-09-25

US20250297025A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#3 | 2025-07-10

US20250223372A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#4 | 2023-11-16

US20230365702A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#5 | 2022-11-17

US20220363771A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#6 | 2022-10-13

US20220324955A1

Chemistry; metallurgy

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

#7 | 2022-09-29

US20220306761A1

Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#8 | 2022-08-18

US20220259327A1

Chemistry; metallurgy

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

#9 | 2022-05-12

US20220144963A9

Chemistry; metallurgy

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

#10 | 2022-02-17

US20220049020A1

Chemistry; metallurgy

TETRAVALENT MULTISPECIFIC ANTIBODIES

#11 | 2021-09-30

US20210301030A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#12 | 2021-07-01

US20210198383A1

Chemistry; metallurgy

Method for determining the in vivo interaction mode

#13 | 2021-03-11

US20210070882A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#14 | 2020-11-26

US20200369758A1

Chemistry; metallurgy

Bispecific antigen binding proteins

#15 | 2020-11-05

US20200347147A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#16 | 2020-08-06

US20200247904A1

Chemistry; metallurgy

Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer

#17 | 2020-07-23

US20200231673A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#18 | 2020-07-09

US20200216554A1

Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#19 | 2020-03-26

US20200095310A1

Chemistry; metallurgy

Fc-receptor binding modified asymmetric antibodies and methods of use

#20 | 2019-12-19

US20190382507A1

Chemistry; metallurgy

Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer

#21 | 2018-11-01

US20180312573A1

Chemistry; metallurgy

Nucleic acid encoding dual Fc antigen binding proteins

#22 | 2018-08-09

US20180222993A1

Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#23 | 2018-08-09

US20180222992A1

Chemistry; metallurgy

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

#24 | 2018-08-09

US20180222981A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#25 | 2018-08-09

US20180222980A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#26 | 2018-03-22

US20180079805A1

Chemistry; metallurgy

Bispecific antigen binding proteins

#27 | 2018-02-08

US20180037633A1

Chemistry; metallurgy

Monovalent antigen binding proteins

#28 | 2017-09-14

US20170260265A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

#29 | 2017-08-31

US20170247441A1

Chemistry; metallurgy

Anti-ANG2 antibodies and methods of use

#30 | 2017-08-31

US20170247440A1

Chemistry; metallurgy

Anti-PDGF-B antibodies and methods of use

#31 | 2017-08-24

US20170240629A1

Chemistry; metallurgy

Bispecific antibodies and methods of use in ophthalmology

#32 | 2017-07-06

US20170190783A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#33 | 2017-06-22

US20170174786A1

Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#34 | 2017-05-25

US20170145116A1

Chemistry; metallurgy

TETRAVALENT MULTISPECIFIC ANTIBODIES

#35 | 2017-05-11

US20170129962A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#36 | 2016-07-14

US20160200833A1

Chemistry; metallurgy

Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

#37 | 2016-06-09

US20160159894A1

Chemistry; metallurgy

Human FcRn-binding modified antibodies and methods of use

#38 | 2016-03-17

US20160075785A1

Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#39 | 2015-04-09

US20150099699A1

Human necessities

Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

#40 | 2015-01-01

US20150004166A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#41 | 2014-03-06

US20140065707A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#42 | 2014-03-06

US20140065151A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#43 | 2014-01-16

US20140017244A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

#44 | 2013-06-20

US20130156789A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#45 | 2013-03-14

US20130065831A1

Chemistry; metallurgy

Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

#46 | 2012-12-20

US20120321627A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#47 | 2012-09-20

US20120237506A1

Chemistry; metallurgy

Dual FC antigen binding proteins

#48 | 2012-06-07

US20120142091A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#49 | 2012-06-07

US20120141500A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#50 | 2011-12-01

US20110293613A1

Chemistry; metallurgy

Bispecific antibodies

#51 | 2010-12-23

US20100322934A1

Chemistry; metallurgy

Bispecific, tetravalent antigen binding proteins

#52 | 2010-12-16

US20100316645A1

Chemistry; metallurgy

Bispecific antigen binding proteins

#53 | 2010-10-07

US20100256338A1

Chemistry; metallurgy

Multispecific antibodies comprising full length antibodies and single chain fab fragments

#54 | 2010-06-24

US20100159587A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#55 | 2010-05-13

US20100121036A1

Chemistry; metallurgy

Method for the production of insulin-like growth factor-1

#56 | 2010-05-06

US20100111967A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#57 | 2008-05-22

US20080119409A1

Chemistry; metallurgy

Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

#58 | 2006-11-23

US20060263356A1

Chemistry; metallurgy

Antibodies against IL-13 receptor alpha1 and uses thereof

InventorID:

1871275 ⎘